[1] Behrman RE, Kliegman RM, Jenson HB.尼尔森儿科学[M].17版.北京:北京大学医学出版社,2007.[2] 江载芳,申昆玲,沈颖.诸福棠实用儿科学[M].北京:人民卫生出版社,2015: 1859-1868.[3] Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004:14-34.[4] Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program. 2003:40-61.[5] 方建培.铁螯合剂在地中海贫血治疗中的临床应用[J].中国小儿血液与肿瘤杂志,2011,16(6):241-243,255.[6] 张潇予,黄勇.移植前铁过载对血液肿瘤患者异基因造血干细胞移植预后影响的研究进展[J].国际输血及血液学杂志,2014,37(6):538-541.[7] 施圆圆,何祎,冯四洲.铁过载对造血干细胞移植的影响[J]. 白血病•淋巴瘤,2016,25(11):701-704.[8] Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42(12):799-805.[9] Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109(10):4586-4588.[10] Li C, Wu X, Feng X, et al. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation. Blood. 2012;120(19): 3875-3881.[11] 许兰平,黄晓军.干细胞移植的HLA配型和植入证据检测[J].中国实用儿科杂志,2005,20(11):649-651.[12] Sykes M. Mixed chimerism and transplant tolerance. Immunity. 2001;14(4):417-424.[13] 周小鸽,陈辉树.世界卫生组织肿瘤分类、造血与淋巴组织肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:7-113.[14] 和虹,邵宗鸿,刘鸿,等.与异常免疫相关的全血细胞减少症[J].中华血液学杂志,2001,22(2):79-82.[15] 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:567.[16] Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171-2179.[17] Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003;138(8):627-633.[18] 李长钢,刘四喜,王缨,等. 重型13地中海贫血患儿心脏及肝脏铁沉积状态的多中心研究[J].中华儿科杂志,2014,52(2):90-93.[19] Kolnagou A, Natsiopoulos K, Kleanthous M, et al. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*. Toxicol Mech Methods. 2013;23(1): 48-56.[20] Emond MJ, Bronner MP, Carlson TH, et al. Quantitative study of the variability of hepatic iron concentrations. Clin Chem. 1999;45(3): 340-346.[21] Kataoka K, Nannya Y, Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(2): 195-204.[22] 吴学东,井远方,裴夫瑜,等.磁共振成像(T2*)检测重型地中海贫血患者心脏、肝脏铁负荷及其临床意义[J].南方医科大学学报, 2013,33(2): 249-252.[23] Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120(20):1961-1968.[24] 彭鹏,龙莉玲,黄仲奎,等.β-重型地中海贫血MRI定量心脏铁沉积与血清铁蛋白、肝铁浓度相关性研究[J].中华放射学杂志,2012,46(11):993-997.[25] Leung AW, Chu WC, Lam WW, et al. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. Pediatr Blood Cancer. 2009;53(6):1054-1059.[26] Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171-2179.[27] Altes A, Remacha AF, Sarda P, et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant. 2004;34(6):505-509.[28] 柴笑,赵明峰. 铁过载在血液系统疾病中的危害及治疗进展[J].中华内科杂志,2013,52(5):431-433.[29] Tachibana T, Tanaka M, Takasaki H, et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. Int J Hematol. 2011;93(3):368-374.[30] Weinberg ED. Iron availability and infection. Biochim Biophys Acta. 2009;1790(7):600-605.[31] Bullen JJ, Rogers HJ, Spalding PB, et al. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol. 2006; 55(Pt 3):251-258.[32] Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2(12):946-953.[33] Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis. 2007;11(6):482-487.[34] Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant. 2008;41(12):997-1003.[35] Sahlstedt L, von Bonsdorff L, Ebeling F, et al. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Eur J Haematol. 2009;83(5):455-459.[36] Evens AM, Mehta J, Gordon LI. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant. 2004;34(7):561-571.[37] von Bonsdorff L, Sahlstedt L, Ebeling F, et al. Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron. FEMS Immunol Med Microbiol. 2004;40(2):173-180.[38] Caroline L, Taschdjian CL, Kozinn PJ, et al. Reversal of serum fungistasis by addition of iron. J Invest Dermatol. 1964;42:415-419.[39] Esterly NB, Brammer SR, Crounse RG. The relationship of transferrin and iron to serum inhibition of Candida albicans. J Invest Dermatol. 1967;49(5):437-442.[40] Artis WM, Patrusky E, Rastinejad F, et al. Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation. Infect Immun. 1983;41(3):1269-1278.[41] Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.[42] Patton N, Brown G, Leung M, et al. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events. Intern Med J. 2010;40(6):419-426. |